The association of quantitative EEG and MRI in Creutzfeldt-Jakob Disease.


Journal

Acta neurologica Scandinavica
ISSN: 1600-0404
Titre abrégé: Acta Neurol Scand
Pays: Denmark
ID NLM: 0370336

Informations de publication

Date de publication:
Nov 2019
Historique:
received: 14 04 2019
revised: 07 07 2019
accepted: 28 07 2019
pubmed: 9 8 2019
medline: 21 12 2019
entrez: 9 8 2019
Statut: ppublish

Résumé

Previous studies showed concordance between the typical Periodic Sharp Wave Complex (PSWC) activity in EEG of Creutzfeldt-Jakob Disease (CJD) patients and the MRI findings, while the concordance with slow activity in EEG is less established. The aim of this study was to better characterize the association between MRI findings and EEG changes using quantitative EEG (qEEG) analysis. The demographics, clinical features, and the MRI findings of 12 familial E200K patients with CJD were gathered. EEG test was done and reviewed for the typical PSWC and for the non-specific slow activity. A possible association between the MRI findings and the EEG activity was examined. Then, EEG was analyzed using qEEG tool, and the association between the qEEG finding and the MRI was examined. Twelve patients were included in the study (67% women). Cortical MRI lesions finding were seen in 6/12 (50%) of the patients, and deep gray mater lesions were seen in 8/12 patients (67%). EEG showed the classic PSWC in 6/12 (50%) of the patients where slow activity was seen in 10/12 (83%). Slow activity and cortical MRI findings were associated in only 2/6 (33%) where deep gray matter findings and the slow activity had concordance of 4/8 (50%). qEEG analysis improved this concordance between slow activity and cortical findings to 3/6 (50%) and with the deep gray matter findings to 5/8 (63%). Quantitative EEG analysis modesty but not significantly, improves the association of EEG slow activity in familial E200K CJD patients with MRI findings.

Identifiants

pubmed: 31393995
doi: 10.1111/ane.13154
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

366-371

Subventions

Organisme : NIH Clinical Center
ID : NS043488

Informations de copyright

© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

Knight RS, Will RG. Prion diseases. J Neurol Neurosurg Psychiatry. 2004;75:i36-i42.
Korczyn AD. Creutzfeldt-Jakob disease among Libyan Jews. Eur J Epidemiol. 1991;7:490-493.
Goldfarb LG, Korczyn AD, Brown P, Chapman J, Gajdusek DC. Mutation in codon 200 of scrapie amyloid precursor gene linked to Creutzfeldt-Jakob disease in Sephardic Jews of Libyan and non-Libyan origin. Lancet. 1990;336:637-638.
Hsiao K, Meiner Z, Kahana E, et al. Mutation of the prion protein in Libyan Jews with Creutzfeldt-Jakobdisease. N Engl J Med. 1991;324:1091-1097.
Appel SA, Chapman J, Kahana E, et al. Rapidly progressive Creutzfeldt-Jakob disease in patients with familial Mediterranean fever. Eur J Neurol. 2010;1(17):861-865.
WHO. Global surveillance, diagnosis and therapy of human transmissible spongiform encephalopathies: report of the WHO consultation. In: World Health Organization: emerging and other communicable diseases, surveillance and control, Geneva, 1998:9-11.
Zerr I, Kallenberg K, Summers DM, et al. Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain. 2009;132:2659-2668.
Hansen HC, Zschocke S, Sturenburg HJ, Kunze K. Clinical changes and EEG patterns preceding the onset of periodic sharp wave complexes in Creutzfeldt-Jakob disease. Acta Neurol Scand. 1998;97:99-106.
Gibson LM, Chappell FM, Summers D, et al. Post-mortem magnetic resonance imaging in patients with suspected prion disease: pathological confirmation, sensitivity, specificity and observer reliability. A national registry. PLoS ONE. 2018;7(13):e0201434.
Caobelli F, Cobelli M, Pizzocaro C, Pavia M, Magnaldi S, Guerra UP. The role of neuroimaging in evaluating patients affected by Creutzfeldt-Jakob disease: a systematic review of the literature. J Neuroimaging. 2015;25:2-13.
Caverzasi E, Mandelli ML, DeArmond SJ, et al. White matter involvement in sporadic Creutzfeldt-Jakob disease. Brain. 2014;137:3339-3354.
Lee H, Cohen OS, Rosenmann H, et al. Cerebral white matter disruption in Creutzfeldt-Jakob disease. AJNR Am J Neuroradiol. 2012;33:1945-1950.
Cohen OS, Chapman J, Korczyn AD, et al. Familial Creutzfeldt-Jakob disease with the E200K mutation: longitudinal neuroimaging from asymptomatic to symptomatic CJD. J Neurol. 2015;262:604-613.
Seror I, Lee H, Cohen OS, Hoffmann C, Prohovnik I. Putaminal volume and diffusion in early familial Creutzfeldt-Jakob disease. J Neurol Sci. 2010;15(288):129-134.
Cohen OS, Chapman J, Korczyn AD, et al. Clinical radiological correlation in E200K familial Creutzfeldt-Jakob disease. J Neural Transm. 2016;123:1457-1462.
Na DL, Suh CK, Choi SH, et al. Diffusion-weighted magnetic resonance imaging in probable Creutzfeldt-Jakob disease: a clinical-anatomic correlation. Arch Neurol. 1999;56:951-957.
Cambier DM, Kantarci K, Worrell GA, Westmoreland BF, Aksamit AJ. Lateralized and focal clinical, EEG, and FLAIR MRI abnormalities in Creutzfeldt-Jakob disease. Clin Neurophysiol. 2003;114:1724-1728.
Kandiah N, Nagaendran K, Tan K, et al. Creutzfeldt-Jakob disease:which diffusion-weighted imaging abnormality is associated with periodic EEG complexes? J Neurol. 2008;255:1411-1414.
Mizobuchi M, Tanaka C, Sako K, Nihira A, Abe T, Shirasawa A. Correlation between periodic sharp wave complexes and diffusion-weighted magnetic resonance images in early stage of Creutzfeldt-Jakob disease: a report of two cases. Seizure. 2008;17:717-722.
Appel SA, Chapman J, Prohovnik I, Hoffman C, Cohen OS, Blatt I. The EEG in E200K familial CJD: relation to MRI patterns. J Neurol. 2012;259:491-496.
Nuwer M. Assessment of digital EEG, quantitative EEG, and EEG brain mapping: report of the American Academy of Neurology and the American Clinical Neurophysiology Society. Neurology. 1997;49:277-292.
Smailovic U, Koenig T, Kåreholt I, et al. Quantitative EEG power and synchronization correlate with Alzheimer's disease CSF biomarkers. Neurobiol Aging. 2018;63:88-95.
Geraedts VJ, Boon LI, Marinus J, et al. Clinical correlates of quantitative EEG in Parkinson disease: a systematic review. Neurology. 2018;91:871-883.
Lewine JD, Plis S, Ulloa A, et al. Quantitative EEG biomarkers for mild traumatic brain injury. J Clin Neurophysiol. 2019;36:298-305.
Franko E, Wehner T, Joly O, et al. Quantitative EEG parameters correlate with the progression of human prion diseases. J Neurol Neurosurg Psychiatry. 2016;87:1061-1067.
Shi QI, Xiao K, Chen C, et al. Clinical and laboratory features of 14 young Chinese probable sCJD patients. Prion. 2017;4(11):128-135.
Boesenberg C, Schulz-Schaeffer WJ, Meissner B, et al. Clinical course in young patients with sporadic Creutzfeldt-Jakob disease. Ann Neurol. 2005;58:533-543.

Auteurs

Shmuel Appel (S)

Department of Neurology, Barzilai University Medical Center, Ashkelon, Israel.
Faculty of Health Sciences, Ben Gurion University of the Negev, Beer-Sheva, Israel.

Oren S Cohen (OS)

Department of Neurology, Assaf Harofeh Medical Center, Zerifin, Israel.
Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Joab Chapman (J)

Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Department of Neurology, The Sagol Neuroscience Center, and Chaim Sheba Medical Center, Ramat Gan, Israel.

Shlomo Gilat (S)

Gilat Medical LTD, Pardes-hana, Israel.

Hanna Rosenmann (H)

Department of Neurology, Hadassah Hebrew University Medical Center, Jerusalem, Israel.

Zeev Nitsan (Z)

Department of Neurology, Barzilai University Medical Center, Ashkelon, Israel.
Faculty of Health Sciences, Ben Gurion University of the Negev, Beer-Sheva, Israel.

Ester Kahan (E)

Department of Neurology, Barzilai University Medical Center, Ashkelon, Israel.
Faculty of Health Sciences, Ben Gurion University of the Negev, Beer-Sheva, Israel.

Ilan Blatt (I)

Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Department of Neurology, The Sagol Neuroscience Center, and Chaim Sheba Medical Center, Ramat Gan, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH